Status: Recruiting
A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines
The objective of this Phase 2 study is to assess the safety and efficacy of single treatment of trenibotulinumtoxinE and onabotulibumtoxinA combination in adult participants with moderate to severe upper facial lines. The study has two parts; Part 1 evaluates treatment for glabellar lines.
Participants needed: 300
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: AbbVieUpdated: Oct 13, 2026Locations: 1
Eligibility criteria
For glabellar lines (GL) indication: participant must have moderate or severe GL... [+2]
For GL Indication: Severe GL at rest as assessed by the investigator using the A... [+3]